Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174808 · ClinicalTrials.gov registry record · NA
Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03174808 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 3 participants.
The verdict
NCT03174808, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The primary objective is to assess the feasibly, adherence, and effects of mindfulness-based stress reduction (MBSR) on anxiety and health-related quality of life in adult patients with cutaneous T-cell lymphoma at the Yale Cancer Center/Smilow Cancer Hospital. Participants will attend group sessions led by an instructor experienced in MBSR in an academic setting. The mindfulness meditation group sessions will take place at the Smilow Cancer Center at the Yale New-Haven Hospital.
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-08-20 |
| Est. Completion | 2018-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03174808
The ClinicalTrials.gov registry entry for NCT03174808 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT03174808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03174808 about?
NCT03174808 is a clinical study titled "Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)". The primary objective is to assess the feasibly, adherence, and effects of mindfulness-based stress reduction (MBSR) on anxiety and health-related quality of life in adult patients with cutaneous T-cell lymphoma at the Yale Cancer Center/Smilow Cancer Hospital. Participants will attend group sessio...
What is the current status of trial NCT03174808?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-08-20. Estimated completion is 2018-11-26.
What interventions are being tested in trial NCT03174808?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03174808?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.